Physician profile
Robert J Larke
NPI 1881919744
$21,662.33
in general payments reported to CMS, 2019-2025
62 companies · $2,539 in 2025
The $2,539 reported for 2025 was more than what 84% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,801 · 2020: $1,208 · 2021: $1,516 · 2022: $8,779 · 2023: $2,634 · 2024: $3,185 · 2025: $2,539.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,290 · Education: $68.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,289.90 |
| Education | $68.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $8,046.83 | 2019-2025 | |
| Astellas Pharma US INC | $1,287.10 | 2019-2025 | Xtandi, Myrbetriq |
| Calyxo, INC. | $1,035.16 | 2024-2025 | Cvac Aspiration System |
| Dendreon Pharmaceuticals LLC | $984.89 | 2019-2025 | Provenge |
| Merck Sharp & Dohme LLC | $677.19 | 2020-2025 | Lynparza, Keytruda, Welireg |
| Axonics, INC. | $654.10 | 2020-2024 | Axonics |
| Janssen Biotech, INC. | $554.75 | 2019-2025 | Erleada |
| Sumitomo Pharma America, INC. | $543.64 | 2023-2025 | Orgovyx, Gemtesa |
| Urogen Pharma, INC. | $527.12 | 2020-2025 | Jelmyto |
| Antares Pharma, INC. | $481.16 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Astrazeneca Pharmaceuticals LP | $461.74 | 2020-2025 | Lynparza |
| Abbvie INC. | $455.23 | 2019-2025 | |
| Boston Scientific Corporation | $423.12 | 2019-2025 | Ams 700, General - Erectile Dysfunction, Axonics |
| Ferring Pharmaceuticals INC. | $364.27 | 2019-2025 | Adstiladrin |
| Myovant Sciences INC. | $351.37 | 2021-2022 |
Show all 62 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $312.82 | 2019-2025 | |
| Blue Earth Diagnostics | $291.42 | 2019-2022 | |
| Janssen Scientific Affairs, LLC | $271.19 | 2023-2025 | Erleada, Akeega, Pipeline |
| Endo Pharmaceuticals INC. | $264.60 | 2019-2023 | Xiaflex, Aveed, Edex |
| Accord Healthcare, INC. | $254.10 | 2023-2025 | |
| Tolmar Pharmaceuticals, INC. | $252.91 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $243.69 | 2019-2024 | Yonsa |
| Novartis Pharmaceuticals Corporation | $211.82 | 2024-2025 | |
| Progenics Pharmaceuticals, INC. | $193.87 | 2022-2025 | |
| Endo USA, INC. | $183.48 | 2024-2025 | Xiaflex, Aveed |
| 180 Medical, INC. | $182.47 | 2019-2025 | |
| Myriad Genetic Laboratories, INC. | $174.17 | 2023-2025 | Prolaris |
| C. R. Bard, INC. & Subsidiaries | $129.90 | 2020-2021 | |
| Zyla Life Sciences, INC. | $124.40 | 2019-2020 | |
| Olympus America INC. | $123.29 | 2025 | Itind System |
| Medtronic, INC. | $121.94 | 2022-2025 | Interstim, Altaviva |
| Coloplast Corp | $121.33 | 2020-2023 | Porges Coloplast |
| Bioprotect Medical, INC. | $116.55 | 2024 | Bioprotect Balloon Implant System |
| Foundation Medicine, INC. | $115.41 | 2020-2023 | |
| Immunitybio, INC. | $113.48 | 2024-2025 | |
| Amgen INC. | $88.03 | 2019-2023 | Prolia |
| Procept Biorobotics Corporation | $81.52 | 2019-2022 | |
| Urovant Sciences INC | $72.22 | 2021-2022 | |
| Verity Pharmaceuticals INC. | $71.06 | 2023-2025 | Trelstar, Tlando |
| Teleflex LLC | $59.34 | 2023-2025 | Urolift |
| Laborie Medical Technologies Corp. | $56.94 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Halozyme INC | $56.87 | 2023 | |
| Neotract INC. | $55.93 | 2019 | |
| Edap Technomed INC | $54.00 | 2024 | |
| Baxter Healthcare | $45.67 | 2023 | Perclot, Tachosil |
| Convatec INC. | $41.37 | 2022 | |
| Clarus Therapeutics INC. | $32.12 | 2021 | |
| Clovis Oncology, INC. | $29.58 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $29.39 | 2025 | Ultomiris |
| Angiodynamics, INC. | $28.91 | 2023-2024 | Nanoknife |
| Cumberland Pharmaceuticals, INC. | $28.57 | 2019 | |
| Acerus Pharmaceuticals Corporation | $25.69 | 2020-2021 | |
| Alnylam Pharmaceuticals INC. | $20.91 | 2022 | |
| Photocure INC | $18.55 | 2024 | Cysview |
| Telix Pharmaceuticals | $18.51 | 2024 | Illuccix |
| Genzyme Corporation | $15.84 | 2023 | |
| Allergan, INC. | $15.46 | 2021 | |
| Karl Storz Endoscopy-America | $14.82 | 2024 | |
| Profound Medical Corp. | $14.11 | 2022 | |
| Baudax Bio INC. | $12.41 | 2020 | |
| Dentsply Ih INC. | $12.34 | 2021 | |
| Dornier Medtech America, INC | $11.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Larke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.